Lifeboat Foundation

Samsara Therapeutics has completed a seed financing round in collaboration with Apollo Ventures, a venture capital company and biotech incubator that supports longevity research and treatments for age-related diseases.

Samsara Therapeutics, Inc. (“Samsara,”) a platform biotechnology startup engaged in the discovery and development of compounds that address the primary molecular causes of aging, announced today the closing of a seed financing round. The financing was led by Apollo Ventures, a life sciences venture capital firm and company builder working across Europe and North America.

Additionally, on February 19th, 2019 Nature Communications published a peer-reviewed paper, “The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species” authored by Samsara’s scientific team [1]. The paper demonstrates the capability of the Samsara platform to identify novel MoA geroprotective small molecules that extend healthy lifespan across species and which are protective in mammalian models of disease.

Continue reading “Samsara is Developing Autophagy Boosting Therapies to Combat Aging” »

Late last year, archaeologists in China found some very interesting items in an ancient tomb dating back as far as 202 BC, including a bronze vessel that somehow still held liquid. The liquid, which at the time was thought to be some type of wine, has since undergone closer examination that reveals its true purpose.

China’s Xinhua news agency is now reporting that the beverage was actually an “elixir of immortality” that matches descriptions from ancient documents. The substance has been tested and, if scientists are right about it, there’s probably little chance it would do anything to extend someone’s life, and may even usher death in even quicker.

After Anton Zeldin’s wife was involved in a fatal car accident, he chose to have her brain frozen with the hope that she can one day be brought back to life. Video Journalist: Irina Sedunova.

The role of epigenetics, which determine how your genes are expressed, is being increasingly implicated in aging, as is the potential of therapies that revert epigenetics back to those of a younger person.

What are epigenetic alterations?

The DNA in each of our cells is identical, with only some small variations, so why do our various organs and tissues look so different, and how do cells know what to become?

Continue reading “Epigenetic Alterations and Reprogramming Potential in Aging” »

The longevity sector is showing signs of being taken more seriously. On Tuesday, Mehmood Khan, vice chairman and chief scientific officer of PepsiCo, announced he’s joining Life Biosciences, a startup dedicated to “age-reversal.” Khan will become the startup’s CEO and a member of its board of directors.

Science seeks to fix aging and death. But a Christian vision of the good life might actually embrace them.

Aubrey de Grey is getting more bullish about his timeframes for robust human rejuvenation and longevity escape velocity. He now thinks it is only 18 years away and not 25 years anymore.

There is fastly progressing science and there is a rapid increase in funding and formation of companies. Areas that were making slow progress like Mitosens are now rapidly progressing. Cross-linking is making progress as well.

Continue reading “Aubrey de Grey Thinks Robust Human Longevity Might Be Here by 2037” »

Medical advances and living standards have extended the average human longevity from 48 years in 1955 to 71 years today, and the elderly are now the fastest growing segment of society. But while our life spans are improving, our health spans are not, writes science journalist Sue Armstrong in “Borrowed Time: The Science of How and Why We Age” (Bloomsbury), out now.

“Over the past 50 years, health care hasn’t slowed the aging process so much as it has slowed the dying process,” she writes, quoting gerontologist Eileen Crimmins.

Continue reading “Science has figured out how to freeze the aging process” »